NCT01258491View on ClinicalTrials.gov

Study to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of a Single Oral Repeated Dose of 500 mg Nicotinic Acid as Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

December 31, 2005

Conditions
Healthy Subjects
Interventions
DRUG

Nicotinic Acids

All Listed Sponsors
lead

Heidelberg University

OTHER

NCT01258491 - Study to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of a Single Oral Repeated Dose of 500 mg Nicotinic Acid as Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter